CCL2 and Farber lipogranulomatosis: JWH133 treatment of Farber disease mice also led to a reduction of MCP‐1 in tissues and plasma, and treatment of these mice by enzyme replacement therapy (ERT) led to a reduction of plasma CB2R, indicating its potential to monitor treatment response.